Human basophil histamine release is differently affected by inhibitors of calmodulin, diacylglycerol kinase and peptidyl prolyl cis‐trans isomerase in a secretagogue specific manner

Allergy

Volumn 47, Issue 4, 1992, Pages 353-361

  Bergstrand, H ^a   Lundquist, B ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

A23187; anti IgE; calmidazolium; CGS 9343B, felodipine; FK506; FMLP; H 186 86; ionomycin; metofenazate; PMA; R 59 022; Ro 22 4839

Indexed keywords

3 DECANOYL 1,2 ISOPROPYLIDENEGLYCEROL; 6 [2 [4 [(4 FLUOROPHENYL)PHENYLMETHYLENE] 1 PIPERIDYL]ETHYL] 7 METHYL 5H THIAZOLO[3,2 A]PYRIMIDIN 5 ONE; CALMIDAZOLIUM; CALMODULIN; DIACYLGLYCEROL KINASE; DIHYDROPYRIDINE DERIVATIVE; ELZIVERINE; FELODIPINE; H 186 86; IMMUNOGLOBULIN E; ISOMERASE; METOFENAZATE; PROTEIN KINASE C; TACROLIMUS; UNCLASSIFIED DRUG; ZALDARIDE MALEATE;

ADULT; ARTICLE; BASOPHIL; FEMALE; HISTAMINE RELEASE; HUMAN; HUMAN CELL; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

AMINO ACID ISOMERASES; BASOPHILS; BENZIMIDAZOLES; CALMODULIN; CARRIER PROTEINS; COMPARATIVE STUDY; DIACYLGLYCEROL KINASE; FELODIPINE; HISTAMINE RELEASE; HUMAN; IMIDAZOLES; ISOQUINOLINES; PEPTIDYLPROLYL ISOMERASE; PHENOTHIAZINES; PHOSPHOTRANSFERASES; PYRIMIDINONES; TACROLIMUS; THIAZOLES;

EID: 0026656713     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1992.tb02071.x     Document Type: Article

References (50)

1. 2+ and of pH provides sequential, synergistic signals for secretion in antigen‐stimulated rat basophilic leukemia (RBL‐2H3) cells
2. 9): Partial characterization of secretagogue characteristics
3. Modulation of human leukocyte histamine release by sn‐1,2‐isopropylidene‐3‐decanoyl‐glycerol and decanoic acid cyclopentyl methylester in comparison with effects of synthetic diacylglycerols and a phorbol ester
4. Comparison of the action of calcium antagonists on basophil histamine release
5. Pharmacology of cyclosporine (Sandimmune). IV. Pharmacological properties in vivo
6. Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin
7. Differential inhibition of histamine release from human basophils induced by antigen, anti‐IgE or N‐formyl‐L‐methionyl‐L‐leucyl‐L‐phenylalanine
8. 2 release from human leukocytes and human chopped lung mast cells by the allergic mediator release inhibitor, CI‐949
9. 2+ ionophore
10. Metabolic comparison between basophils and other leukocytes from human blood
11. R 59 022, a diacylglycerol kinase inhibitor. Its effect on diacylglycerol and thrombin‐induced C kinase activation in the intact platelet
12. + cells
13. Calmidazolium, a calmodulin antagonist, stimulates calcium‐troponin C and calcium‐calmodulin‐dependent activation of striated muscle myofilaments
14. A receptor for the immunosuppressant FK506 is a cis‐trans peptidyl‐prolyl isomerase
15. Polymyxin B is a selective and potent antagonist of calmodulin
16. Inhibition of inositol trisphosphate‐stimulated calcium mobilization by calmodulin antagonists in rat liver epithelial cells
17. Immunophilin ligands demonstrate common features of signal transduction leading to exocytosis or transcription
18. Differential effects of the diacylglycerol kinase inhibitor R59022 on thrombin versus collagen‐induced human platelet secretion
19. Cyclosporine
20. Diacylglycerol kinase: a key modulator of signal transduction
21. Differential activation of human basophils by anti‐IgE and formyl‐methionyl‐leucyl‐phenylalanine. Implications for protein kinase C‐dependent and ‐independent activation pathways
22. The mechanism of basophil histamine release induced by antigen and by the calcium ionophore A23187
23. Calcineurin is a common target of cyclophilin‐cyclosporin A and FKBP‐FK506 complexes
24. Antigen‐induced secretion of histamine and the phosphorylation of myosin by protein kinase C in rat basophilic leukemia cells
25. Assessment of IgE‐receptor function through measurement of hydrolysis of membrane inositol phospho‐lipids. New insights on the phenomena of biphasic antigen concentration‐response curves and desensitization
26. The inhibition of arachidonic acid mobilization in human platelets by R59 022, a diacylglycerol inhibitor
27. Possible role of calmodulin in the control of histamine release from human basophil leukocytes
28. Molecular aspects of receptors and binding factors for IgE
29. The receptor with high affinity for immunoglobulin E
30. Tumor promoter‐induced basophil histamine release: Effect of selected flavanoids
31. Role of protein kinase C in histamine release from human basophils
32. Selective calmodulin inhibition toward myosin light chain kinase by a new cerebral circulation improver, Ro 22–4839
33. 2+
34. CGS 9343B, a novel, potent and selective inhibitor of calmodulin activity
35. 9)
36. Porcine 80‐kDa diacylglycerol kinase is a calcium‐binding and calcium/phospholipid‐dependent enzyme and undergoes calcium‐dependent translocation
37. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation
38. Release of histamine from human leukocytes stimulated with the tumor‐promoting phorbol dicsters. I. Characterization of the response
39. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl‐prolyl isomerase activity but is distinct from cyclophilin
40. An automated continuous‐flow system for the extraction and fluorimetric analysis of histamine
41. Mechanism of histamine release by formyl methionine‐containing peptides
42. Activation of protein kinase C by the dihydropyridine calcium channel blocker, felodipine
43. FK‐506 enters the clinic
44. 8‐induced histamine release from human basophils by the protein kinase C inhibitors, H‐7 and H‐9
45. Metofenazate as a more selective calmodulin inhibitor than trifluoperazine
46. Effect of felodipine (a dihydropyridine calcium channel blocker) and analogues on calmodulin‐dependent enzymes
47. Protein kinase C (PKC) changes in human basophils. IgE‐mediated activation is accompanied by an increase in total PKC activity
48. Signal transduction events in human basophils. A comparative study of the role of protein kinase C in basophils activated by anti‐IgE antibody and formyl‐methionyl‐leucyl‐phenylalanine
49. The effect of pertussis toxin on mediator release from human basophils
50. Effects of calmidazolium on calpain activity and the calpain calpastatin interaction